About Us

The Converse Pharma Group is a privately UK owned group of companies. The group was formed in 2013 following a successful MBO of three established trading businesses. The deal backed by the Royal Bank of Scotland brought together the DE Group, Doncaster Pharmaceutical Group and Eurodrug.

The primary focus of the group is the wholesale distribution of pharmaceutical products throughout the UK and the Republic of Ireland. The group operates from 12 sites, serving over 5500 customers, employing close to 800 people and with a turnover of £250m in 2017.

Key Facts

Our Aim
What We Believe
Our Philosophy

Meet Our Team

David Horry
David HorryChairman and CEO
  • Over 20 years of senior board level experience
  • Previously Managing Director of Intercare PLC (now part of Alliance Healthcare)
  • Joined the group board in 2013 following the succcessful MBO
Mark Gulliford
Mark GullifordManaging Director - DE Group
  • Over 25 years of pharmaceutical industry experience
  • Member of the DE Group board since 1998
  • Managed the sale of the business to Mawdsley Brooks in 2007
  • Partner in the 2013 MBO
Andy Wilson
Andy WilsonGroup Finance and Operations Director
  • Qualified Chartered Accountant
  • Over 20 years pharmaceutical industry experience
  • Previously Finance Director of Intercare PLC (now part of Alliance Healthcare)
  • Joined Doncaster Pharmaceuticals in 2004
  • Partner in the 2013 MBO

Performance


converse trading customers 2016

converse group perf 2016